Friday, 22 March 2013

Analysis: J&J's answer to Botox may escalate war on wrinkles

By Ransdell Pierson NEW YORK (Reuters) - Johnson & Johnson may soon cause frown lines at Allergan Inc, maker of Botox. J&J expects to seek U.S. approval next year for an anti-wrinkle drug that could break Botox's near monopoly, an 85 percent m...

Source: http://health.yahoo.net/news/s/nm/analysis-j-j-s-answer-to-botox-may-escalate-war-on-wrinkles

found it for you found it I found it found here

No comments:

Post a Comment

Note: only a member of this blog may post a comment.